Research Article
Have access already?
Get access to this article:
Or get access to the particular issue:
- Perpetual access Add to cart ($49.95)
Or get access to the entire journal:
Abstract
Medication nonadherence remains a significant obstacle to achieving improved health outcomes in patients with chronic disease. Self-efficacy, the confidence in one’s ability to perform a given task such as taking one’s medications, is an important determinant of medication adherence, indicating the need for reliable and valid tools for measuring this construct. This study sought to develop a self-efficacy scale for medication adherence in chronic disease management that can be used in patients with a broad range of literacy skills. The Self-efficacy for Appropriate Medication Use (SEAMS) was developed by a multidisciplinary team with expertise in medication adherence and health literacy. Its psychometric properties were evaluated among 436 patients with coronary heart disease and other comorbid conditions. Reliability was evaluated by measuring internal consistency and test-retest reliability. Principal component factor analysis was performed to evaluate the validity of the SEAMS. Reliability and validity analyses were also performed separately among patients with low and higher literacy levels. The final 13-item scale had good internal consistency reliability (Cronbach’s α = 0.89). A two-factor solution was found, explaining 52.3% of the scale’s variance. The scale performed similarly across literacy levels. The SEAMS is a reliable and valid instrument that may provide a valuable assessment of medication self-efficacy in chronic disease management, and appears appropriate for use in patients with low literacy skills.
Period | Abstract | Full | Total | |
---|---|---|---|---|
Apr 2024 | 95 | 0 | 2 | 97 |
Mar 2024 | 92 | 0 | 1 | 93 |
Feb 2024 | 123 | 0 | 3 | 126 |
Jan 2024 | 232 | 0 | 1 | 233 |
Dec 2023 | 168 | 0 | 1 | 169 |
Nov 2023 | 144 | 0 | 1 | 145 |
Oct 2023 | 124 | 0 | 2 | 126 |
Sep 2023 | 199 | 0 | 1 | 200 |
Aug 2023 | 103 | 0 | 0 | 103 |
Jul 2023 | 116 | 0 | 1 | 117 |
Jun 2023 | 104 | 0 | 3 | 107 |
May 2023 | 148 | 0 | 2 | 150 |
Apr 2023 | 100 | 0 | 0 | 100 |
Mar 2023 | 107 | 0 | 2 | 109 |
Feb 2023 | 104 | 0 | 2 | 106 |
Jan 2023 | 159 | 0 | 1 | 160 |
Dec 2022 | 88 | 0 | 1 | 89 |
Nov 2022 | 110 | 0 | 3 | 113 |
Oct 2022 | 153 | 0 | 0 | 153 |
Sep 2022 | 169 | 0 | 2 | 171 |
Aug 2022 | 180 | 0 | 0 | 180 |
Jul 2022 | 204 | 0 | 0 | 204 |
Jun 2022 | 99 | 0 | 0 | 99 |
May 2022 | 141 | 0 | 0 | 141 |
Apr 2022 | 178 | 0 | 0 | 178 |
Mar 2022 | 287 | 0 | 6 | 293 |
Feb 2022 | 146 | 0 | 3 | 149 |
Jan 2022 | 109 | 0 | 0 | 109 |
Dec 2021 | 150 | 0 | 1 | 151 |
Nov 2021 | 130 | 0 | 1 | 131 |
Oct 2021 | 186 | 0 | 3 | 189 |
Sep 2021 | 80 | 0 | 2 | 82 |
Aug 2021 | 49 | 0 | 0 | 49 |
Jul 2021 | 67 | 0 | 0 | 67 |
Jun 2021 | 48 | 0 | 1 | 49 |
May 2021 | 169 | 0 | 0 | 169 |
Apr 2021 | 170 | 0 | 0 | 170 |
Mar 2021 | 138 | 0 | 0 | 138 |
Feb 2021 | 159 | 0 | 0 | 159 |
Jan 2021 | 141 | 0 | 1 | 142 |
Dec 2020 | 141 | 0 | 1 | 142 |
Nov 2020 | 100 | 0 | 0 | 100 |
Oct 2020 | 245 | 0 | 0 | 245 |
Sep 2020 | 135 | 0 | 0 | 135 |
Aug 2020 | 61 | 0 | 2 | 63 |
Jul 2020 | 70 | 0 | 0 | 70 |
Jun 2020 | 76 | 0 | 1 | 77 |
May 2020 | 135 | 0 | 1 | 136 |
Apr 2020 | 156 | 0 | 2 | 158 |
Mar 2020 | 113 | 0 | 0 | 113 |
Feb 2020 | 101 | 0 | 2 | 103 |
Jan 2020 | 153 | 0 | 0 | 153 |
Dec 2019 | 261 | 0 | 0 | 261 |
Nov 2019 | 57 | 0 | 0 | 57 |
Oct 2019 | 29 | 0 | 0 | 29 |
Sep 2019 | 29 | 0 | 0 | 29 |
Aug 2019 | 21 | 0 | 0 | 21 |
Jul 2019 | 11 | 0 | 0 | 11 |
Jun 2019 | 6 | 0 | 0 | 6 |
May 2019 | 11 | 0 | 1 | 12 |
Apr 2019 | 14 | 0 | 1 | 15 |
Mar 2019 | 42 | 0 | 0 | 42 |
Feb 2019 | 30 | 0 | 2 | 32 |
Jan 2019 | 17 | 0 | 0 | 17 |
Dec 2018 | 11 | 0 | 0 | 11 |
Nov 2018 | 20 | 0 | 0 | 20 |
Oct 2018 | 14 | 0 | 4 | 18 |
Sep 2018 | 12 | 0 | 0 | 12 |
Aug 2018 | 7 | 0 | 0 | 7 |
Jul 2018 | 5 | 0 | 0 | 5 |